Cardiovascular disease (CVD) affects approximately 77% of the elderly, community-dwelling Medicare population and is the largest driver of hospital admissions, deaths, and health expenditures in this group. Since 2006, the subsidized Part D drug benefit has improved the accessibility of needed medications for people in Medicare, but the specific effects on those with CVD are not well-known, in particular in terms of medication adherence, use of health services, and patient outcomes. Moreover, nothing is known about major trends in these outcomes among elderly Medicare enrollees with CVD in the eight years following Part D implementation. Using strong quasi-experimental methods and the nationally-representative Medicare Current Beneficiary Survey (2000-2013), we will identify the population of elderly Medicare patients with CVD during a 14-year period and evaluate immediate and longer-term changes in their utilization and clinical outcomes following Part D. Study measures will include demographic and clinical attributes, drug and non-drug utilization, cost-related medication nonadherence, acute hospital events, and perceived health status. For the period after Part D implementation, we will develop and examine new measures including patient cost-coping strategies, month-to-month adherence, and out-of-plan purchasing. For high-risk CVD patients (those with drug spending near or above the Part D "donut hole" coverage gap threshold), we will estimate changes in outcomes following the sudden 2011 improvement in brand name drug coverage within this coverage gap. In particular, we will examine changes in adherence and CVD treatment intensity for Part D patients in or near the coverage gap, by therapeutic drug class and by brand versus generic status.

Public Health Relevance

The effects of Medicare Part D implementation on access to medicines and changes in health services and outcomes are poorly understood for the large population of elderly with cardiovascular disease. Our study aims to investigate changes in these important outcomes in the 8 years following Part D implementation, in particular after a large 2011 discount on branded medicines for patients entering the donut hole coverage gap.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Research Project (R01)
Project #
Application #
Study Section
Health Services Organization and Delivery Study Section (HSOD)
Program Officer
Bhattacharyya, Partha
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Harvard Pilgrim Health Care, Inc.
United States
Zip Code
Naci, Huseyin; Soumerai, Stephen B; Ross-Degnan, Dennis et al. (2014) Medication affordability gains following Medicare Part D are eroding among elderly with multiple chronic conditions. Health Aff (Millwood) 33:1435-43
Naci, Huseyin; Soumerai, Stephen B; Ross-Degnan, Dennis et al. (2014) Persistent medication affordability problems among disabled Medicare beneficiaries after Part D, 2006-2011. Med Care 52:951-6
Harrold, Leslie R; Briesacher, Becky A; Peterson, Dan et al. (2013) Cost-related medication nonadherence in older patients with rheumatoid arthritis. J Rheumatol 40:137-43
Blanchard, Janice; Madden, Jeanne M; Ross-Degnan, Dennis et al. (2013) The relationship between emergency department use and cost-related medication nonadherence among medicare beneficiaries. Ann Emerg Med 62:475-85
Zivin, Kara; Madden, Jeanne M; Graves, Amy J et al. (2009) Cost-related medication nonadherence among beneficiaries with depression following Medicare Part D. Am J Geriatr Psychiatry 17:1068-76
Madden, Jeanne M; Graves, Amy J; Ross-Degnan, Dennis et al. (2009) Cost-related medication nonadherence after implementation of Medicare Part D, 2006-2007. JAMA 302:1755-6
Madden, Jeanne M; Graves, Amy J; Zhang, Fang et al. (2008) Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA 299:1922-8
Briesacher, Becky A; Gurwitz, Jerry H; Soumerai, Stephen B (2007) Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med 22:864-71